Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho

NAActive, not recruitingINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

March 23, 2025

Study Completion Date

May 31, 2026

Conditions
Type 2 Diabetes Mellitus (T2D)
Interventions
OTHER

T2D care package

T2D care package including lifestyle counselling, firstline antidiabetic (metformin) and lipid-lowering (statin) treatment for uncomplicated T2D and treatment support and regular check-ups for complicated T2D at village-level. Guidance will be provided via the ComBaCaL app. In case of complicated disease referral to the closest health facility for further management.

OTHER

Referral to the responsible health facility

CC-VHWs will refer participants to the responsible health facility for therapeutic management. The ComBaCaL app supports clinical decision making and documentation for screening, diagnosis and referral, but not prescription/provision and monitoring of antidiabetic or lipid-lowering medication for uncomplicated T2D patients or treatment support for complicated T2D patients.

Trial Locations (2)

4051

University of Basel, Division of Clinical Epidemiology, Basel

Unknown

SolidarMed Lesotho, Maseru

All Listed Sponsors
collaborator

Swiss Agency for Development and Cooperation (SDC)

UNKNOWN

collaborator

World Diabetes Foundation (WDF)

UNKNOWN

collaborator

SolidarMed

OTHER

lead

University Hospital, Basel, Switzerland

OTHER